TABLE 10. Recommended vaccination schedule and intervals for college freshmen living in residence halls* and military recruits — Advisory Committee on Immunization Practices, United States, 2020.

Age group	Serogroups A, C, W, and Y meningococcal conjugate vaccines MenACWY-D (Menactra, Sanofi Pasteur)† or MenACWY-CRM (Menveo, GlaxoSmithKline)§ or MenACWY-TT (MenQuadfi, Sanofi Pasteur)¶	Serogroup B meningococcal vaccines MenB-FHbp (Trumenba, Pfizer) or MenB-4C (Bexsero, GlaxoSmithKline)
≥10 yrs	Primary vaccination: MenACWY-D or MenACWY-CRM or MenACWY-TT: 1 dose Boosters**: • College freshmen living in residence halls: Not routinely recommended unless person becomes at increased risk due to another indication • Military recruits: Every 5 yrs on basis of assignment††	No recommendations for use of MenB vaccines in this population unless otherwise indicated See Table 2 for recommendations in persons aged 16–23 yrs

Abbreviations: MenACWY-CRM = meningococcal groups A, C, W, and Y oligosaccharide diphtheria CRM₁₉₇ conjugate vaccine; MenACWY-D = meningococcal groups A, C, W, and Y polysaccharide diphtheria toxoid conjugate vaccine; MenACWY-TT = meningococcal groups A, C, W, and Y polysaccharide tetanus toxoid conjugate vaccine; MenB-4C = four-component meningococcal group B vaccine; MenB-FHbp = meningococcal group B factor H binding protein vaccine.

* College freshmen living in residence halls should receive at least 1 dose of MenACWY within 5 years before college entry. The preferred timing of the most recent dose is on or after their 16th birthday. If only 1 dose of vaccine was administered before the 16th birthday, a booster dose should be administered before enrollment. Adolescents who received a first dose after their 16th birthday do not need another dose before college entry unless it has been more than 5 years since the dose. Some schools, colleges, and universities have policies requiring vaccination against meningococcal disease as a condition of enrollment.

^† Licensed in the United States only for persons aged 9 months–55 years. Vaccination of persons aged ≥56 years is considered off-label.

^§ Licensed in the United States only for persons aged 2 months–55 years. Vaccination of persons aged ≥56 years is considered off-label.

^¶ Licensed in the United States only for persons aged ≥2 years.

^** Licensed in the United States only for a single booster dose for persons aged 15–55 years for MenACWY-D and MenACWY-CRM or aged ≥15 years for MenACWY-TT. Booster doses administered outside of these ages or administration of >1 booster dose are considered off-label.

^†† Vaccination recommendations for military personnel are made by the U.S. Department of Defense on the basis of high-risk travel requirements.